Dr. A. van Hylckama Vlieg Announced Winner of the first EHA-ISTH Joint Fellowship
|
Dr Ian Peake and Dr Astrid |
Dr. A. van Hylckama Vlieg was recently awarded the very first Joint Fellowships of the European Hematology Association (EHA)-International Society on Thrombosis and Haemostasis (ISTH) at EHA’s 16th Annual Congress in London, UK.
The award of EUR 72,000 over two years is intended to support the study of the physiology of bleeding, coagulation or thrombosis. Dr. van Hylckama Vlieg’s proposal, Ageing of the venous valves and the risk of venous thrombosis in the elderly, aims to clarify which factors predict venous thrombosis in the elderly. The study, referred to as BATAVIA (Biology of Ageing and Thrombosis: Appraisal of Valve thickness and function, an In vivo Assessment, is an extension of her previous work with the AT-AGE (Age and Thrombosis: Acquired and Genetic risk factors in the Elderly) study.
Dr. van Hylckama Vlieg’s proposal was selected from 18 competitive submissions for this joint program of EHA and ISTH. “We are very pleased with the number of high-quality research proposals received in response to this initiative in its first year,” said Dr. Ian Peake, Co-Chair of the EHA-ISTH Joint Fellowship Review Committee and a past president of ISTH.
“I am very happy to receive this award, said Dr. van Hylckama Vlieg. It is an honor to be the first recipient of this unique collaboration between ISTH and EHA.”
Since 2009, Dr. van Hylckama Vlieg has served a joint appointment as Senior Clinical Researcher with Leiden University in the Netherlands and the University of Washington in Seattle, Washington, USA. Her research has been focused on the combined effect between hormone use, such as contraceptives and hormone replacement therapies, and statins. Her general research interests have been on venous thrombosis, a common condition of clotting in the veins.
Prior to 2009 Dr. van Hylckama Vlieg was a Clinical Researcher in the Department of Clinical Epidemiology at Leiden University Medical Center. She completed her PhD at Leiden University in 2003 and was a post-doctoral research fellow at Addenbrooke’s NHS Trust Hospital in the UK. Dr. van Hylckama Vlieg’s work has been published in a number of international journals, including Blood, Journal of Thrombosis and Haemostasis, Arteriosclerosis, Thrombosis, and Vascular Biology and the British Medical Journal. She has been awarded a number of grants and prizes from organizations such as the Dutch Heart Foundation, Foundation LeDucq, and the British Society for Haematology, among others.
Information about the call for applications for the next EHA-ISTH Joint Fellowship will be available later this year on the websites of EHA and ISTH.
